Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adherence to Minimally Invasive CRC Screening In Non-Adherent Patients Who Have Not Completed Colorectal Cancer Screening

NCT02251782 is registered in ClinicalTrials.gov with Epigenomics, Inc as lead sponsor.

NCT NCT02251782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02251782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adherence to Minimally Invasive CRC Screening In Non-Adherent Patients Who Have Not Completed Colorectal Cancer Screening
Lead sponsor
Epigenomics, Inc
Phase
Observational
Overall status
Completed
Start date
October 31, 2014
Completion date
June 30, 2015
Enrollment
490 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer